When was Catalyst Clinical founded?

Catalyst Clinical was founded in 2004.

Where is Catalyst Clinical located?

Catalyst Clinical is headquartered in Delhi, India. It is registered at UG- 11 UPPER GROUND AGGARWAL PRESTIGE MALL PLOT NO. 2 ROAD NO. 44, PITAMPURA, North West, DELHI, Delhi, India, 110034.

Who is the current CEO of Catalyst Clinical?

Pankaj Gupta of Catalyst Clinical.

How many employees does Catalyst Clinical have?

As of Jul 01, 2024, the latest employee count at Catalyst Clinical is 11.

Is Catalyst Clinical a funded company?

Catalyst Clinical is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Catalyst Clinical?

Annual revenue of Catalyst Clinical is ₹3.71Cr as on Mar 31, 2025.

Where does Catalyst Clinical rank among its competitors?

Catalyst Clinical ranks 177th amongst 343 active competitors, of which 14 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Veristat, which secured $1.33M in Dec, 2021.

Who are the top competitors of Catalyst Clinical?

Catalyst Clinical's top competitors include TFS, Parexel and Syneos Health. Among them, Veristat secured the most recent funding round in December, 2021.

Catalyst Clinical - 2026 Company Profile, Team, Competitors & Financials

Company Details

Catalyst Clinical Services offers a range of clinical development services to pharma and biotech companies. The company's core services include Clinical Trials Management and Execution, Medical Writing, Independent Auditing and Clinical Research Training. Catalyst also offers Project Management, Data Management and Regulatory Support Services. The company claims to have experience in conducting phase II, III and IV clinical trials in the therapeutic areas of Oncology, Endocrinology, Critical care, Cardiology, Andrology, CNS, Ophthalmology, Infectious Diseases and Medical Devices. The company claims that it has been chosen by the University of Oxford, London for setting up and coordinating the research activities for Cancer Clinical Trials Network in India and UK and also to have been appointed by Ministry of Science and Technology, Government of India for project management and monitoring of several clinical trials sponsored by them.

Website: www.catalystclinicalservices.com/
Social
Registered Address: UG- 11 UPPER GROUND AGGARWAL PRESTIGE MALL PLOT NO. 2 ROAD NO. 44, PITAMPURA, North West, DELHI, Delhi, India, 110034

Key Metrics

Founded Year

2004

Location

Delhi, India

Stage

Unfunded

Ranked

177^th among 343 active competitors

Annual Revenue

₹3.71Cr as on Mar 31, 2025

Employee Count

11 as on Jul 01, 2024

Similar Companies

TFS & 408 more

View Catalyst Clinical's full profile

Catalyst Clinical is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Gabriel Research Consulting Llp CIN: AAN-8008 , India, Active	Dec 19, 2018	-	-
CATALYST CLINICAL SERVICES PRIVATE LIMITED CIN: U24239DL2004PTC125941 , India, Active	Apr 21, 2004	$439K (As on Mar 31, 2025)	-

Catalyst Clinical has not raised any funding rounds yet.

Catalyst Clinical's employee count trend

Catalyst Clinical has 11 employees as of Jul 24. Here is Catalyst Clinical's employee count trend over the years:

Employee count trend for Catalyst Clinical

Uncover Catalyst Clinical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Catalyst Clinical include TFS, Parexel and Syneos Health. Here is the list of Top 10 competitors of Catalyst Clinical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TFS 1996, Lund (Sweden), Acquired	A global mid-service CRO providing clinical research services	-	-	64/100
2nd	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Boston Capital Ventures, Vedanta Capital & 2 others	62/100
3rd	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Adams Street Partners, First Analysis & 1 others	61/100
4th	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	60/100
5th	Celgene 1986, Summit (United States), Acquired	Developer of therapies for treating cancer and inflammatory diseases	$45M	Piper Jaffray, BB Biotech & 12 others	56/100
6th	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, WindRose Health Investors ... & 2 others	56/100
7th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	56/100
8th	Emmes 1977, India, Acquired	Provider of outsourced CRO services	-	Behrman Capital, Apollo Investment Corporation ... & 1 others	54/100
9th	hVIVO 1998, London (United Kingdom), Public	Provider of cell based assays, field trial, and molecular services for biopharma sector	-	Woodford Investment Management, IP Group	51/100
10th	Premier Research 1989, Durham (United States), Public	Provider of clinical trial CRO services	-	alzheimerlondon.ca, Indigo Capital & 4 others	50/100
177th	Catalyst Clinical 2004, Delhi (India), Unfunded	CRO offering clinical development services for clinical trials from Phase II to IV	-	-	26/100